Cure8 research brief
Noninvasive imaging that better separates inflammation from fibrosis and detects penetrating complications could change monitoring and treatment decisions in IBD and reduce radiation exposure for patients needing frequent follow-up.
Clinicians managing IBD, radiologists and nuclear medicine specialists, researchers developing molecular tracers and imaging protocols, and pediatric/young-adult patients who require long-term monitoring.
This article is a review (abstract-level content provided here) summarizing current evidence that 18F-FDG PET quantifies metabolic inflammatory burden while FAPI-targeted PET may better highlight fibro-inflammatory remodeling, which could help distinguish fibrotic strictures from active inflammation.
The review highlights PET/MRI as a promising option for assessing penetrating complications and for longitudinal monitoring with lower radiation exposure — potentially useful in pediatric and young adult patients — but notes most supporting data come from small, single-center or experimental studies, so these modalities are currently adjunctive rather than replacements for endoscopy or standard cross-sectional imaging.
The field is exploring new tracers, ultra–low-dose whole-body systems, and AI-based reconstruction, but standardized multicenter protocols are still needed before broad clinical implementation.
This entry is based on the article abstract (review) rather than a pooled meta-analysis of large multicenter trials. The review states that current data are largely from small or experimental studies, so findings are promising but not yet practice-changing.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study points to a possible noninvasive brain-based biomarker that correlates with intestinal fibrosis severity in Crohn’s disease, a complication that’s hard to detect and treat. This could eventually help identify...
New PET tracers like FAPI could better detect fibrosis and stromal activity than standard FDG-PET, which may improve imaging of fibrostenotic Crohn's disease. For people with IBD, improved imaging might eventually help...
AI could help make IBD assessments (endoscopy, histology, imaging, biomarkers) more objective and faster, which may improve monitoring, treatment selection, and early detection of complications for people with Crohn’s...
